Idiopathic Pulmonary Fibrosis

January 19, 2015November 5, 2015

OFEV® (nintedanib*) Approved By The EU For Idiopathic Pulmonary Fibrosis

Boehringer Ingelheim today announced that nintedanib has been approved by the European Commission (EC) for the treatment of idiopathic pulmonary fibrosis (IPF), joining the recent approval by the FDA in the U.S. back in October of ... Read more

January 16, 2015November 5, 2015

Mitochondrial Malfunction And Enzyme Deficiency Discovery Helps Explain Lung Fibrosis Association With Advancing Age

Idiopathic Pulmonary Fibrosis, News

A Pittsburgh School of Medicine research team examining cells sampled from the scar tissue in the lungs of patients with idiopathic pulmonary fibrosis (IPF) made a surprising discovery: misshapen, bloated ... Read more

January 9, 2015November 5, 2015

Pacific Therapeutics Announces 2015 Strategy Focused on IPF

Idiopathic Pulmonary Fibrosis, News

Clinical stage specialty pharmaceutical company Pacific Therapeutics has announced its new strategy for 2015, as well as corporate updates to its shareholders, expressing its continued focus on the treatment of ... Read more

January 5, 2015November 5, 2015

Interstitial Lung Disease Patient Benefits from Stem Cell Therapy

Idiopathic Pulmonary Fibrosis, News

The Lung Institute, a regenerative medicine center that treats patients with lung disease through stem cell therapy (SCT), recently shared the developments of one of their case studies on how SCT can ... Read more

January 5, 2015November 5, 2015

Coalition for Pulmonary Fibrosis Celebrated Historic Year Progress in 2014

Idiopathic Pulmonary Fibrosis, News

The Coalition for Pulmonary Fibrosis (CPF) a 501C(3) nonprofit organization founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), says 2014 was a history-making ... Read more

December 11, 2014November 5, 2015

iBio Releases Updates on Promising IPF and SSc Pipeline Treatment

Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

iBio, Inc., a specialist in developing plant-based therapeutics, hosted shareholders and attendees at its Annual Meeting on Thursday, December 11, and presented a comprehensive update on the company’s ongoing activities ... Read more

December 10, 2014November 5, 2015

New Idiopathic Pulmonary Fibrosis Biomarkers Aid in Determining Disease Severity

Idiopathic Pulmonary Fibrosis, News

A new study entitled “Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis” suggests the level of the surfactant protein D (SP-D) ... Read more

December 1, 2014November 5, 2015

Lipids in the Lungs Found To Be Pulmonary Fibrosis Cause

Idiopathic Pulmonary Fibrosis, News

A recent study entitled “A Pneumocyte-macrophage Paracrine Lipid Axis Drives the Lung Toward Fibrosis” reports an increased accumulation of lipids in lung tissue triggers pulmonary fibrosis. The study was published ... Read more

November 26, 2014November 5, 2015

CHMP Publishes Positive Opinion of Nintedanib IPF Drug

Idiopathic Pulmonary Fibrosis, News

Nintedanib, Boehringer Ingelheim’s treatment for patients with idiopathic pulmonary fibrosis (IPF), recently received positive opinions from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ... Read more

November 18, 2014November 5, 2015

Do Lungs Already Know How To Reverse Lung Damage?

Idiopathic Pulmonary Fibrosis, News

A new study entitled “p63+/Krt5+ distal airway stem cells are essential for lung regeneration” unravels the regenerative capacity of a group of lung stem cells and highlights their potential use ... Read more